Real-World Evidence of Effectiveness and Safety of Vedolizumab for Inflammatory Bowel Disease in Taiwan: A Prospective Nationwide Registry (VIOLET) Study.
暂无分享，去创建一个
Jia‐Feng Wu | Y. Ni | M. Shieh | J. Wong | Deng-Chyang Wu | I. Wu | H. Yen | C. Tu | Chien-Yu Lu | Keng-Liang Wu | C. Chung | W. Hsu | Fang-Jung Yu | Huang-Ming Hu | J. Chou | C. Feng | Chung-hsin Chang | Shu‐Chen Wei | C. Chuang | Huann‐Sheng Wang | M. Wong | W. Tai | T. Tsai | Hung-Hsin Lin | I. Feng | Chun-Chi Lin | F. Chiang | T. Chao | Lung‐Sheng Lu | Tien-Yu Huang | C. Tung | Hsin-Yu Kuo | A. Ho | Chia‐Chang Chen | Peng-Hsu Chen | Wei‐Chen Lin | Yu-hwa Liu | Hsiang Yao Shih | Shu-Lun Tang | Chung-Hsin Chang | Hsin‐Yu Kuo | Lung‐Sheng Lu | I-Chen Wu